GCVRX
Price
$24.23
Change
+$0.14 (+0.58%)
Updated
Jul 3 closing price
Net Assets
534.73M
VIVIX
Price
$70.10
Change
+$0.40 (+0.57%)
Updated
Jul 3 closing price
Net Assets
188.77B
Interact to see
Advertisement

GCVRX vs VIVIX

Header iconGCVRX vs VIVIX Comparison
Open Charts GCVRX vs VIVIXBanner chart's image
Goldman Sachs Large Cp Val Insghts R
Price$24.23
Change+$0.14 (+0.58%)
VolumeN/A
Net Assets534.73M
Vanguard Value Index I
Price$70.10
Change+$0.40 (+0.57%)
VolumeN/A
Net Assets188.77B
GCVRX vs VIVIX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
GCVRX vs. VIVIX commentary
Jul 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GCVRX is a Buy and VIVIX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VIVIX has more cash in the bank: 189B vs. GCVRX (535M). VIVIX pays higher dividends than GCVRX: VIVIX (2.19) vs GCVRX (0.66). GCVRX was incepted earlier than VIVIX: GCVRX (18 years) vs VIVIX (27 years). GCVRX (1.27) is less costly to investors than VIVIX (0.04). GCVRX is a more actively managed with annual turnover of: 206.00 vs. VIVIX (9.00). GCVRX has a lower initial minimum investment than VIVIX: GCVRX (0) vs VIVIX (5000000). VIVIX annual gain was more profitable for investors over the last year : 11.41 vs. GCVRX (0.61). VIVIX return over 5 years is better than : 79.11 vs. GCVRX (34.75).
GCVRXVIVIXGCVRX / VIVIX
Total Expense Ratio1.170.042,925%
Annual Report Gross Expense Ratio1.270.043,175%
Fund Existence18 years27 years-
Gain YTD5.3565.60995%
Front LoadN/AN/A-
Min. Initial Investment05000000-
Min. Initial Investment IRAN/AN/A-
Net Assets535M189B0%
Annual Yield % from dividends0.662.1930%
Returns for 1 year0.6111.415%
Returns for 3 years20.3334.4059%
Returns for 5 years34.7579.1144%
Returns for 10 years54.08114.4547%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SKYE4.610.87
+23.26%
Skye Bioscience
CHKP223.634.24
+1.93%
Check Point Software Technologies Ltd
QFIN43.110.37
+0.87%
Qifu Technology
PGY22.16-0.02
-0.09%
Pagaya Technologies Ltd
SNSE9.03-0.24
-2.54%
Sensei Biotherapeutics Inc